Usana Health Sciences (USNA) Depreciation & Amortization (CF) (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $8.3 million in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 0.74% year-over-year to $8.3 million in Q2 2026; TTM through Apr 2026 was $32.5 million, a 64.81% increase from a year earlier, with the FY2026 full-year figure at $32.6 million, up 123.96% from the prior year.
• Depreciation & Amortization (CF) for Q2 2026 stood at $8.3 million, down from $8.6 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for USNA reached as high as $8.6 million in Q1 2026 and fell as low as $2.5 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $4.7 million across 5 years, with a median of $3.4 million in 2022.
• Across the five-year window, Depreciation & Amortization (CF) declined 11.54% in 2023 and surged 164.06% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $3.3 million in 2022, then fell by 11.54% to $2.9 million in 2023, then soared by 37.33% to $4.0 million in 2024, then soared by 98.02% to $7.9 million in 2025, then increased by 4.52% to $8.3 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $8.3 million in Q2 2026, $8.6 million in Q1 2026, and $7.9 million in Q3 2025.